Literature DB >> 1344923

[Neurological toxicity of amiodarone. 5 case reports].

A Arnaud1, J P Neau, T Rivasseau-Jonveaux, R Marechaud, R Gil.   

Abstract

Five patients developed neurological adverse effects as they were treated with amiodarone for 2 to 18 months. The daily maintenance dose did not exceed 400 mg. The neurological manifestations included tremor, ataxia, peripheral neuropathy, dyskinesia, myoclonic jerks, extrapyramidal hypertony, and altered mental status. These side effects resolved within 3 days to 3 months after amiodarone withdrawal. Advanced age, renal failure, diabetes mellitus, and alcoholism seemed to be risk factors for development of amiodarone neurotoxicity. Both peripheral and central nervous systems are involved in these amiodarone-induced complications.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1344923

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  2 in total

1.  Unusual amiodarone toxicity in a child.

Authors:  Bahram Kakavand; Thomas G Di Sessa
Journal:  J Pediatr Pharmacol Ther       Date:  2008-04

2.  Amiodarone-induced hepatitis and polyneuropathy.

Authors:  Hyun Mo Kang; Yoon Sae Kang; Seok Hyun Kim; Jae Kyu Seong; Dae Young Kang; Heon Young Lee; Byung Seok Lee
Journal:  Korean J Intern Med       Date:  2007-09       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.